Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00144001 · ClinicalTrials.gov registry record

Factors Associated With in Suboptimal Prescribing for Older Patients With Epilepsy

A clinical trial, sponsored by US Department of Veterans Affairs.

Completed
Registry status
9,682
Enrollment target

NCT00144001 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 9,682 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00144001 has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
9,682 participants
Enrollment target

Study Summary

Nearly 2% of veterans \>65 are actively treated for epilepsy, and the incidence is projected to increase with the aging of our society. Since commonly used antiepileptic drugs are considered suboptimal for older patients, it is important to understand existing patterns of treatment for older veterans with epilepsy.

Trial Details

FieldValue
Enrollment Target 9,682 participants
Start Date 2000-10
Est. Completion 2008-09

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00144001

The ClinicalTrials.gov registry entry for NCT00144001 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9,682 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00144001 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00144001 about?

NCT00144001 is a clinical study titled "Factors Associated With in Suboptimal Prescribing for Older Patients With Epilepsy". Nearly 2% of veterans \>65 are actively treated for epilepsy, and the incidence is projected to increase with the aging of our society. Since commonly used antiepileptic drugs are considered suboptimal for older patients, it is important to understand existing patterns of treatment for older veteran...

What is the current status of trial NCT00144001?

This trial is currently completed. The enrollment target is 9,682 participants. The study started on 2000-10. Estimated completion is 2008-09.

Who is sponsoring clinical trial NCT00144001?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.